Incidence of ANCA-associated vasculitis and polyarteritis nodosa in Norfolk, UK, from 2011 to 2020

被引:0
|
作者
Fordham, Sarah [1 ]
Ashurst, Karen [2 ]
Bartoletti, Alice [1 ]
Coath, Fiona L. [1 ]
Ducker, Georgina [1 ]
Kamath, Ajay [3 ]
Mushtaq, Warda [1 ]
Naeem, Hassan [1 ]
Nicholls, Isabelle [1 ]
Sheehy, Claire [1 ]
Sisson, Katherine [1 ]
Watts, Richard [4 ]
Mukhtyar, Chetan B. [1 ]
机构
[1] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Dept Rheumatol, Norwich, England
[2] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Dept Immunol, Norwich, England
[3] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Dept Resp Med, Norwich, England
[4] Univ East Anglia, Norwich Med Sch, Norwich, England
关键词
granulomatosis with polyangiitis; microscopic polyangiitis; eosinophilic granulomatosis with polyangiitis; polyarteritis nodosa; epidemiology; RHEUMATOLOGY; 1990; CRITERIA; CHURG-STRAUSS-SYNDROME; SYSTEMIC VASCULITIS; INCREASING INCIDENCE; WEGENERS-GRANULOMATOSIS; CLASSIFICATION; EPIDEMIOLOGY;
D O I
10.1093/rheumatology/keaf052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The aim of this study was to report the annual and age-specific incidence of AAV and PAN in the adult population of Norfolk County, UK.Methods Individuals newly diagnosed with AAV or PAN between 1 January 2011 and 31 December 2020 residing in the postal areas of NR1-NR30 were included. Patients were classified according to the European Medicines Agency algorithm. Population data were available from the Office of National Statistics, UK.Results A total of 164 patients were diagnosed with AAV or PAN over 4.7 million person-years. The annual incidence (95% CI) of AAV was 34.3 (29.2, 40)/million person-years. The annual incidence (95% CI) of granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis was 18.9 (15.2, 23.3), 12.8 (9.7, 16.4) and 2.6 (1.3, 4.5)/million person-years, respectively. The annual incidence (95% CI) for PAN was 0.6 (0.1, 1.9)/million person-years. The age-specific incidence of granulomatosis with polyangiitis and microscopic polyangiitis rose with each decade of life and was highest in the 8th decade for granulomatosis with polyangiitis [53.2 (95% CI 36.2, 75.6) per million] and in the 9th decade for microscopic polyangiitis [48.4 (95% CI 27.1, 79.8) per million].Conclusion The incidence of AAV, specifically that of granulomatosis with polyangiitis and of microscopic polyangiitis, is slowly rising over time. It is most notable among the elderly population, among whom the incidence rates for granulomatosis with polyangiitis and microscopic polyangiitis peak. There may be a 4-year incidence cycle, which needs confirmation in a longer study.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Mortality and cause of death in patients with ANCA-associated vasculitis and polyarteritis nodosa in Australia-a population-based study
    Tieu, Joanna
    Lester, Susan
    Raymond, Warren
    Keen, Helen, I
    Hill, Catherine L.
    Nossent, Johannes
    RHEUMATOLOGY, 2022, 61 (03) : 1062 - 1071
  • [32] Echocardiographic features in patients with ANCA-associated vasculitis within 3 months before and after diagnosis
    Ahn, Sung Soo
    Park, Eun Seong
    Jung, Seung Min
    Song, Jason Jungsik
    Park, Yong-Beom
    Lee, Sang-Won
    CLINICAL RHEUMATOLOGY, 2017, 36 (12) : 2751 - 2759
  • [33] ANCA-associated vasculitis
    Kitching, A. Richard
    Anders, Hans-Joachim
    Basu, Neil
    Brouwer, Elisabeth
    Gordon, Jennifer
    Jayne, David R.
    Kullman, Joyce
    Lyons, Paul A.
    Merkel, Peter A.
    Savage, Caroline O. S.
    Specks, Ulrich
    Kain, Renate
    NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)
  • [34] Farm Exposure as a Differential Risk Factor in ANCA-Associated Vasculitis
    Willeke, P.
    Schlueter, B.
    Sauerland, C.
    Becker, H.
    Reuter, S.
    Jacobi, A.
    Schotte, H.
    PLOS ONE, 2015, 10 (09):
  • [35] Salivary gland involvement in ANCA-associated vasculitis
    Akiyama, Mitsuhiro
    Takanashi, Satoshi
    Takeuchi, Tsutomu
    Kaneko, Yuko
    AUTOIMMUNITY REVIEWS, 2021, 20 (11)
  • [36] Increasing incidence and improved survival in ANCA-associated vasculitis-a Danish nationwide study
    Nelveg-Kristensen, Karl Emil
    Szpirt, Wladimir
    Carlson, Nicholas
    McClure, Mark
    Jayne, David
    Dieperink, Hans
    Gregersen, Jon Waarst
    Krarup, Elizabeth
    Ivarsen, Per
    Torp-Pedersen, Christian
    Egfjord, Martin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (01) : 63 - 71
  • [37] ANCA-Associated Vasculitis Pathogenesis: A Commentary
    Gapud, Eric J.
    Seo, Philip
    Antiochos, Brendan
    CURRENT RHEUMATOLOGY REPORTS, 2017, 19 (04)
  • [38] Accelerated atherosclerosis in ANCA-associated vasculitis
    Gonzalez-Suarez, I.
    Rios-Blanco, J. J.
    Arpa, J.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (06): : 688 - 693
  • [39] Rituximab treatment of ANCA-associated vasculitis
    Raffray, Loic
    Guillevin, Loic
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (08) : 899 - 910
  • [40] Novel Therapies for ANCA-associated Vasculitis
    Monti, Sara
    Brandolino, Fabio
    Milanesi, Alessandra
    Xoxi, Blerina
    Delvino, Paolo
    Montecucco, Carlomaurizio
    CURRENT RHEUMATOLOGY REPORTS, 2021, 23 (06)